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Laparoscopic minilaparotomy in 6 patients using the Maher abdominal elevator facilitated both
quicker enucleation and morcellation of the myoma and suture of the myoma cavity. Myoma reduc-
tion in 12 patients by electrosurgery resulted in a 60% reduction in myoma diameter with failure in
2 patients. This technique may avoid myomectomy and be particularly useful in patients with infer-
tility or near menopause.
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INTRODUCTION
Myomas may require removal because of menstrual
symptoms or infertility when the myoma is in the uterine
cavity or blocking a tube, causing abdominal pain, pres-
sure symptoms on the bladder, or rectum orwhen they are
excessively large and cause abdominal distention.
Myomas have been treated by myomectomy and/or
shrinkage with gonadotropin-releasing hormone (GnRH)
analogs. Myomectomymaybe associated with significant
blood loss (500 ml on average), the risk of blood transfu-
sion (41%), or the need to proceed to undesired hysterec-
tomy because of difficulty controlling hemorrhage (1).
Adhesions may occur in 40% or more of patients having
myomectomy, which may cause infertility or pain (2).
GnRH analogues are used to shrink myomas, the re-
duction being up to 40 to 50% after 12 weeks’ healing (3).
Regrowth usually occurs within 6 to 12 months of cesa-
tion of therapy except in postmenopausal women (3).
Hormone replacement therapy in small doses reduces the
side effects of the drugs (4). Despite the temporary effect
of drug therapy, preoperative GnRH analogues have
proven useful beforemyomectomy by reducing menstrual
blood loss, increasing hemoglobin level, reducing opera-
tive blood loss by up to 40%, reducing the use of blood
transfusion, making operative removal easier, and in-
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creasing the chance of laparoscopic removal (3).
Nevertheless, blood loss at myomectomy after GnRH is
still nearly twice as large as at hysterectomy and may be
a cause for concern (3).
The frequent occurrence of adhesions after myomec-
tomy has not been overcome by the use of Hyskon or
Interceed (5). Nezhat et al (6) demonstratedfew adhesions
(3%) when the myoma cavity was not sutured, compared
with 45% when the cavity was sutured. The myoma cav-
ities sutured may have been larger than those not sutured
in this study. The absence of sutures may lead to indenta-
tions and weakness of the uterine scar. The frequency of
conception in 1,143 women wanting children after my-
omectomy was only 40%, suggesting that postoperative
adhesion formation may be one factor limiting their fer-
tility (2).
We have used two new techniques to deal with my-
omasmmyoma reduction and laparoscopic minilaparo-
tomymto facilitate minimally invasive surgery for




The lack of acceptance of laparoscopic surgery for more
complex surgical procedures may be due to many factors:
the lack of manual contact with anatomical and patho-
logical structures, the longer training period required to
learn the techniques, the loss of visual depth perception,130 C. WOOD and P. MAHER
the need for video-based brain-hand coordination, the in-
creased cost of equipment, and the prolongation of oper-
ations such as myomectomy and hysterectomy.
Laparoscopic minilaparotomy has been developed to
combine the advantages of laparoscopy and laparotom
(7). It depends on the use of an abdominal elevator, (e.g.),
the Maher elevator, and a 2-cm low abdominal transverse
incision. This facilitates access for laparotomy instru-
ments, finger palpation and dissection; binocular vision;
and the avoidance of raised intra-abdominal pressure,
which may predispose to cardiopulmonary compromise,
gas embolus, orthromboembolism. The use oflaparotomy
instruments and finger palpation may also assist surgeons
who find advanced laparoscopy techniques difficult.
The disadvantages ofminilaparotomy are the two6-mm
incisions required to insert the elevator, the extension of
the midline suprapubic incision to 2 or 3 cm, and the cost
of the Maher abdominal elevator. There have been no
hematomas in placement of the abdominal elevator in the
lower abdomen after the site of insertion was standard-
ized. The incisions are made in the thinnest part of the
lower left abdominal wall, lateral to the inferior epigastric
vessels and 2 to 3 cm medial to the anterior superior iliac
spine, which avoids the superficial circumflex iliac ves-
sels. The midline transverse suprapubic incision is made
at least 3 cm below the insertion of the abdominal eleva-
tor. The rectus sheath is incised transversely, and the rec-
tus muscle is split, or if thick and impeding retraction, cut
by electrosurgery. This incision is kept open eitherby nar-
row curved metal retractors, by a 2- to 3-cm length of a
20-ml plastic syringe barrel, orby suturing the peritoneum
to the abdominal skin.
The minilaparotomy incision does not delay recovery
whencomparedwith the usual 0.5- to 1.0-cm laparoscopic
incisions as the former bruises less than the umbilical
puncture site, which involves a blind puncture that tra-
verses thick rectus muscle. The minilaparotomy incision
site is in the nonmoving part of the abdomen, which re-
duces stretching during recovery. Some laparoscopic
techniques utilize 2-cm incisions usually created by blind
dilatation and tearing of a 1-cm incision.
The Maher abdominal elevator costs only $600 and is
made by Cook (Australia). The sharp end is replaceable,
and the main bar is robust. There is a safety shield that
covers the tip. The sharp tip is watched during insertion
as the safety guard only covers the tip after insertion. The
purpose of the shield is to guard against accidental perfo-
ration of tissue when passing the elevator from the entry
wound on the one side of the abdomen to the exit wound
on the other. No complications have been associated with
the use of the elevator. Other abdominal elevators are ef-
fective. The laparofan can be placed before a pneu-
moperitoneum is made, but the cost of the elevator is sev-
eral thousand dollars.
One disadvantage associated with the open port of a
minilaparotomy is that bowel tends to prolapse into the
pelvis because of the absence of raised intra-abdominal
pressure. This may necessitate the use of an extra incision
to insert a forceps capable of safely retracting the bowel,
and a fan-shaped forceps is available for this purpose, or
a narrow pack, which can traverse the 2- to 3-cm incision
can be inserted.
Subjects and Methods
Minilaparotomy was used in association with the Maher
abdominal wall elevator in 6 patients each with one to four
myomas from 5 to 10 cm in diameter. The capsules of the
myomas were incised transversely by a spoon electrode
carrying 70 watts cutting monopolar current. The myoma
was stabilizedby a5-mmdiametermyoma screw. The fore-
finger was inserted through a 2- to 3-cm lower abdominal
incision made over the maximum curvature of the surface
of the myoma. The myoma was enucleated by finger dis-
section (Fig. 1A), and hemostasis was ensured by bipolar
forceps coagulation. The myoma was cut into pieces by a
scalpel and scissors inserted into the abdomen through the
same incision, and the pieces of myoma were further re-
duced in size by morcellation with scissors as they were
pulled through the incision (Fig. 1B). The myoma cavity
was exploredby the fingerand sutured intraperitoneally by
a size 1 vicryl suture held in a long-handled needle holder
normally used at laparotomy, the suture line being visible
both through the incision and the laparoscope (Fig. 1C).
The uterus was held steady by a blunt curette inside the
cavity, and the edges of the suture line were manipulated
by laparoscopically placed grasping forceps.
Results
The operative time in the 6 patients was between 30 and
60 minutes. The patients having a laparoscopic myomec-
tomy were discharged home the next day and had no post-
operative complications. The 2- to 3-cm incision did not
delay recovery in the hospital or at home.
Discussion
An advantage ofthe finger dissectionwhen compared with
instrumental operative laparoscopy techniques was the
speed in enucleation of the myoma. Another advantage of
mechanical elevation of the abdominal wall was that the
incision could be used as a port for long-handled laparo-
tomy instruments. Morcellation and suturing can then beNEW STRATEGIES FOR TREATING MYOMAS 131132 C. WOOD and P. MAHER
Figure 1 A. Finger enucleation of myoma through minilaparotomy incision. B. Morcellation of myoma by scissors or scalpel. C. Suture of myoma
capsule and finger tie of knot through minilaparotomy self-retaining retractor (syringe barrel). (Figure reproduced with permission from Blackwell
Scientific Publications Ltd.)
performed under laparoscopic control or by observation
through the open port, assisted by binocular vision.
MYOMA REDUCTION BY ELECTROSURGERY
Goldfarb (8) demonstrated that coagulation ofmyomas by
Nd:YAG laser may reduce the size ofmyomas by 50% or
obliterate myomas of 2 to 3 cm. This surgery was done in
women who were near menopause, and no regrowth was
noticed over 14 months. The current study explored the
use of coagulative electrocautery in 12 patients with my-
omas. We reported the successful use of electrosurgery in
reducing myomas in 4 patients (9).
Subjects and Methods
Twelve patients with 32 subserous or intramural myomas
were selected for the procedure, 10 with menorrhagia and
2 with infertility only. Two of these patients were in the
previous study. All had pre- and postoperative vaginal ul-
trasonography (Table 1). Hysteroscopywas carried out be-
fore operative laparoscopy to exclude the presence of
intracavity myomas.
The operation was performed by laparoscopy, one ac-
cessory incision in the lower abdomen being for a myoma
screw holding the myoma and another accessory incision
being for a monopolar electro-surgical needle, the
Goldfarb bipolar needle or suction irrigator.
The myoma was first injected with in 50 vasopressin
and the myoma was electrocoagulated using a monopolar
electrosurgical needle and a 50-watt coagulation current
or the bipolar needle with a 100-watt cutting current. Both
needles had 4- to 5-cm bare tips, so care to avoid contact
burns during use was required. A high-density current is
necessary because the long length of the needle disperses
more current.
The needle was inserted deep into the myoma at 1-cm
intervals over its surface. Blanching occurred up to a 1-
cm distance from the point of needle insertion (Fig. 2).NEW STRATEGIES FOR TREATING MYOMAS 133
The myometrium next to the myoma, in a direct line from
the ascending uterine vessels, was also coagulated. One
or two liters of a buffered solution (Ringer’s or
Hartmann’s) was left in the peritoneal cavity at the com-
pletion of the operation.
Results
The results ofthe procedures are shown in Table 1. As men-
tioned, menstrual symptoms were the indications formyoma
reduction in 10patientsand in the other2 patients themyoma
was an incidental finding in young women with infertility.
There was no significant bleeding except in the pa-
tientwho alsohadamyomectomyand lost 150ml ofblood.
Laparoscopy in 5 patients between 3 andl2 months sub-
Table 1 Clinical Characteristics of 10 Menorrhagic Patients
Age of patients
Preoperative diameter ofmyomas
Postoperative diameter of myomas









sequent to surgery showed that only patient had adhe-
sions, and these were related to the myomectomy scar not
to the site ofelectrocoagulation. Postoperative pain lasted
only to 3 days, and there were no complications.
The two patients with persistent menorrhagia had to
have hysterectomies.
Discussion
The successful electrocoagulation of myomas between 3
and 7 cm in diameter suggests that this may be a suitable
method for their treatment. The range of reduction was
large. The two largest myomas, 6 and 7 cm, both shrunk
to 2 and 3 cm, respectively, and regrowth in 5 patients fol-
lowed for 2 or more years has been small, 0 to cm. All
the myomas successfully treated were both subserous and
intramural. The 4-cm myoma unsuccessfully treated was
intramural. It may be difficult to target myomas that are
not protruding from the uterine surface.
Needle bipolar forceps may have the advantage of pre-
cise control of the area of electrocoagulation although the
bipolar needle prongs tended to bend toward each other
on penetration of the myoma.
Figure 2 Electrocoagulation of subserous myoma.134 C. WOOD and P. MAHER
Vasopressin injection into the uterus has been associ-
ated with bradycardia and hypertension in France and is
no longer used there (J. P. Pouly, personal communica-
tion). Electrocoagulation may assure hemostasis without
the use of vasopressin.
The current study excluded myomas larger than 7 cm
because of the possibility that necrosis of large volumes
of tissue may result in absorption of necrotic tissue into
the circulation, with uncertain side effects. Goldfarb
(8,10) reduced the size of larger myomas up to 10 cm. It
is still uncertain whether surgical reduction would lead
to permanent shrinkage; Goldfarb’s patients were close
to menopause when myoma regrowth is also less com-
mon after the use of GnRH analogues. The GnRH ana-
logues cause cell shrinkage, not cell reduction, and this
is why regrowth occurs when estrogen levels return to
normal.
Surgical reduction by cautery or lasercauses cell necro-
sis so that myoma reduction may be permanent. Goldfarb
has found little regrowth after 3 years. The scar formed at
the surgical site of electrocoagulation appeared healthy,
and myometrial thickness was not reduced. However, the
strength of the scar cannot be estimated.
Further testing ofelectrocoagulation in the treatment of
subserous myomas up to 8 cm diameter is suggested. The
possible advantages may be reductions in blood loss, in
the risk of blood transfusion, in the risk of necessity for
hysterectomy, and in postoperative adhesive formation.
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